ADVANCED CANCER
Clinical trials for ADVANCED CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCER trials appear
Sign up with your email to follow new studies for ADVANCED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug PHN-010 tested in patients with advanced cancers
Disease control TerminatedThis early-phase study tested a new drug called PHN-010, which delivers a powerful toxin directly to cancer cells. It involved 26 adults with advanced lung, colon, endometrial, ovarian, or cervical cancers that had already been treated. The main goals were to check safety and fin…
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
Cancer combo trial halted early: what happened?
Disease control TerminatedThis early-stage study tested a new drug (BMS-986258) alone or with another cancer drug (nivolumab) in 92 people with advanced solid tumors like lung, kidney, or breast cancer. The main goal was to check safety and side effects. The study was terminated, meaning it stopped early,…
Matched conditions: ADVANCED CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug called DS-9606a in 88 adults with advanced solid tumors that have a specific protein (Claudin-6). The main goal was to check safety and find the right dose. The study was terminated, so results are limited.
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Cancer drug study halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug, BGB-B3227, alone or with another drug (tislelizumab) in 35 people with advanced solid tumors. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 11, 2026 20:47 UTC